ProFunds Pharmaceuticals UltraSector Fund Service Class (PHPSX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
20.45
-0.36 (-1.73%)
Mar 11, 2025, 5:00 PM EST
-2.48% (1Y)
| Fund Assets | 10.07M |
| Expense Ratio | 2.78% |
| Min. Investment | $5,000 |
| Turnover | n/a |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Dividend Growth | n/a |
| Payout Frequency | n/a |
| Ex-Dividend Date | n/a |
| Previous Close | 20.81 |
| YTD Return | 1.56% |
| 1-Year Return | -0.76% |
| 5-Year Return | 33.79% |
| 52-Week Low | n/a |
| 52-Week High | n/a |
| Beta (5Y) | 0.97 |
| Holdings | 54 |
| Inception Date | Jun 28, 2000 |
About PHPSX
The ProFunds Pharmaceuticals UltraSector Fund Service Class (PHPSX) seeks to measure the performance of certain companies in the pharmaceuticals sector of the U.S. equity market.
Category Trading--Leveraged Equity
Performance Rating Below Average
Risk Rating High
Stock Exchange NASDAQ
Ticker Symbol PHPSX
Share Class Service Class
Index S&P 500 TR
Performance
PHPSX had a total return of -0.76% in the past year. Since the fund's inception, the average annual return has been 1.35%, including dividends.
Other Share Classes
These are alternative share classes of the same fund, from the same provider.
| Symbol | Share Class | Expense Ratio |
|---|---|---|
| PHPIX | Investor Class | 1.78% |
Top 10 Holdings
34.65% of assets| Name | Symbol | Weight |
|---|---|---|
| HSBC SECURITIES USA INC | n/a | 4.86% |
| SOCIETE GENERALE | n/a | 4.17% |
| NATWEST MARKETS PLC | n/a | 3.72% |
| Corcept Therapeutics Incorporated | CORT | 3.57% |
| Longboard Pharmaceuticals, Inc. | LBPH | 3.31% |
| Bristol-Myers Squibb Company | BMY | 3.15% |
| UMB FINANCIAL CORP | n/a | 3.13% |
| Intra-Cellular Therapies, Inc. | ITCI | 3.12% |
| Edgewise Therapeutics, Inc. | EWTX | 2.81% |
| Jazz Pharmaceuticals plc | JAZZ | 2.81% |